Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates

Aimee L. Cunninghama Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USAView further author information

Barbara J. Mannb Department of Medicine, Division of Infectious Diseases and International Heath, University of Virginia, Charlottesville, VA, USA

https://orcid.org/0000-0002-5549-2562 View further author information

Aiping Qinb Department of Medicine, Division of Infectious Diseases and International Heath, University of Virginia, Charlottesville, VA, USAView further author information

Araceli E. Santiagoc Department of Pediatrics, University of Virginia, Charlottesville, VA, USAView further author information

Christen Grasseld Center for Vaccine Development, University of Maryland Baltimore, Baltimore, MD, USAView further author information

Michael Lipskye Department of Pathology, University of Maryland Baltimore, Baltimore, MD, USAView further author information

Stefanie N. Vogelf Department of Microbiology and Immunology, University of Maryland Baltimore, Baltimore, MD, USAView further author information

Eileen M. Barryd Center for Vaccine Development, University of Maryland Baltimore, Baltimore, MD, USACorrespondence[email protected]

https://orcid.org/0000-0002-5326-0047 View further author information

show all

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)

César Millán-Pacheco, Lluvia Rios-Soto, Noé Corral-Rodríguez, Erick Sierra-Campos, Mónica Valdez-Solana, Alfredo Téllez-Valencia & Claudia Avitia-Domínguez. (2023) Discovery of Potential Noncovalent Inhibitors of Dehydroquinate Dehydratase from Methicillin-Resistant Staphylococcus aureus through Computational-Driven Drug Design. Pharmaceuticals 16:8, pages 1148.
Crossref

Ángela Rodríguez, María Maneiro, Emilio Lence, José M. Otero, Mark J. van Raaij, Paul Thompson, Alastair R. Hawkins & Concepción González-Bello. (2023) Quinate-based ligands for irreversible inactivation of the bacterial virulence factor DHQ1 enzyme—A molecular insight†. Frontiers in Molecular Biosciences 10.
Crossref

Kensuke Shibata, Takashi Shimizu, Mashio Nakahara, Emi Ito, Francois Legoux, Shotaro Fujii, Yuka Yamada, Makoto Furutani-Seiki, Olivier Lantz, Sho Yamasaki, Masahisa Watarai & Mutsunori Shirai. (2022) The intracellular pathogen Francisella tularensis escapes from adaptive immunity by metabolic adaptation . Life Science Alliance 5:10, pages e202201441.
Crossref

M. I. Kormilitsyna. (2022) Development of New Live Tularemia Vaccines: Problems and Prospects. Biology Bulletin Reviews 12:2, pages 114-130.
Crossref

Lauren E. Shoudy, Prachi Namjoshi, Gabriela Giordano, Sudeep Kumar, Jennifer D. Bowling, Carl Gelhaus, Eileen M. Barry, Allan J. Hazlett, Brian A. Hazlett, Kristine L. Cooper, Phillip R. Pittman, Douglas S. Reed & Karsten R. O. Hazlett. (2021) The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of Protection. Pathogens 10:12, pages 1646.
Crossref

Brandi E. Hobbs, Courtney A. Matson, Vasileios I. Theofilou, Tonya J. Webb, Rania H. Younis & Eileen M. Barry. (2021) Deletion Mutants of Francisella Phagosomal Transporters FptA and FptF Are Highly Attenuated for Virulence and Are Protective Against Lethal Intranasal Francisella LVS Challenge in a Murine Model of Respiratory Tularemia. Pathogens 10:7, pages 799.
Crossref

Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date